Tremfya Leads TV Pharma Ads in September and Q3
Johnson & Johnson's Tremfya retained the top spot for TV pharma brand ad impressions in September, with a 5.02% impressions share of voice (SOV) and 3.1 billion impressions, following a $32.8 million ad spend.
- Tremfya's ad impressions were primarily from Univision's ¡Despierta América!
- Vicks took the runner-up title, with a 4.71% impressions SOV and 2.9 billion impressions, mainly through CBS and GMA 3: What You Need to Know.
- Skyrizi, from AbbVie, was knocked to third place.
The Proctor and Gamble brand Vicks invested $10.3 million in TV ad spend for September, while Tremfya spent approximately $10 million more than in August.
College football and Spanish language TV delivered the lion’s share of TV pharma ad impressions in September.
Author's summary: Tremfya leads TV pharma ads in September.